http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101329573-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101329573-B1 |
titleOfInvention | Human derived gelatin complex and its use |
abstract | The present invention relates to a human-derived gelatin complex and its use, and more particularly, to a human-derived gelatin / lipoic acid complex in which lipoic acid or α-tocopherylsuccinic acid and a human-derived genetically modified gelatin are chemically bonded. The complex is self-assembled to form nanoparticles, hydrophobic drug encapsulation in the hydrophobic core, and particularly excellent as a drug carrier can be used for delivery of anticancer agents. |
priorityDate | 2011-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.